GWM
HOLX

Geneos Wealth Management’s Hologic HOLX Stock Holding History

Geneos Wealth Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-90
Closed -$5.86K – 2801
2025
Q2 		$5.86K Sell
90
-47
-34% -$2.82K ﹤0.01% 2526
2025
Q1 		$19.2K Buy
137
+104
+315% +$6.89K ﹤0.01% 2326
2024
Q4 		$2.38K Buy
33
+6
+22% +$469 ﹤0.01% 2553
2024
Q3 		$2.2K Buy
+27
New +$2.16K ﹤0.01% 2280
2023
Q1 		– Sell
-26
Closed -$1.95K – 2068
2022
Q4 		$1.95K Buy
+26
New +$1.85K ﹤0.01% 1885
2022
Q2 		– Sell
-10
Closed – – 2672
2022
Q1 		$0 Buy
+10
New +$719 ﹤0.01% 2855
2021
Q2 		– Sell
-171
Closed -$11K – 2967
2021
Q1 		$11K Buy
+171
New +$13K ﹤0.01% 2338
2020
Q2 		– Sell
-11,948
Closed -$397K – 2585
2020
Q1 		$397K Buy
11,948
+11,927
+56,795% +$568K 0.03% 420
2019
Q4 		$1K Hold
21
– – ﹤0.01% 2471
2019
Q3 		$1K Hold
21
– – ﹤0.01% 2408
2019
Q2 		$1K Hold
21
– – ﹤0.01% 2409
2019
Q1 		$1K Sell
21
-579
-97% -$26.1K ﹤0.01% 2324
2018
Q4 		$24K Hold
600
– – ﹤0.01% 1419
2018
Q3 		$24K Hold
600
– – ﹤0.01% 1495
2018
Q2 		$23K Hold
600
– – ﹤0.01% 1386
2018
Q1 		$22K Hold
600
– – ﹤0.01% 1347
2017
Q4 		$25K Hold
600
– – ﹤0.01% 1293
2017
Q3 		$22K Hold
600
– – ﹤0.01% 1281
2017
Q2 		$27K Sell
600
-10,162
-94% -$449K ﹤0.01% 1158
2017
Q1 		$457K Sell
10,762
-684
-6% -$27.9K 0.05% 293
2016
Q4 		$459K Sell
11,446
-294
-3% -$11.3K 0.06% 265
2016
Q3 		$455K Buy
11,740
+23
+0.2% +$868 0.06% 260
2016
Q2 		$408K Hold
11,717
– – 0.06% 285
2016
Q1 		$405K Buy
+11,717
New +$409K 0.06% 275

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Geneos Wealth Management's HOLX Position: Q3 2025 in Review

Geneos Wealth Management sold out of Hologic (HOLX) in Q3 2025, closing a stake of 90 shares — an estimated $5.86K sold.

Geneos Wealth Management first reported a position in HOLX in Q1 2016 and held it in 24 quarters. The position peaked at $459K in Q4 2016. 739 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.

  • Geneos Wealth Management reported no remaining Hologic position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 90 Hologic shares in Q3 2025, an estimated $5.86K.
  • Geneos Wealth Management first reported a position in Hologic in Q1 2016 and held it in 24 quarters.
  • Geneos Wealth Management's Hologic position peaked at $459K in Q4 2016.
  • 739 funds tracked by Wall St. Rank held Hologic as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.